Jeffrey Nugent , , , Chairman and CEO

View bioHide bio

Jeffrey Nugent joined Sientra in 2014 as a board member, prior to becoming the Chairman and CEO in 2015. Mr. Nugent’s experience includes serving as the CEO and Worldwide President of Neutrogena, where he led the acquisition by Johnson & Johnson. Neutrogena is regarded as one of the most successful acquisitions in J&J history. Following Neutrogena, Mr. Nugent became the President and CEO of Revlon, where he led a turnaround in profitability and a global initiative of new product innovation. He was Founder, President and CEO of Precision Dermatology, a multi-channel dermatology and skin care company he established in 2010. The company grew both organically and by M&A and was acquired by Valeant Pharmaceuticals in 2013. He began his career at Johnson & Johnson where he held a number of senior responsibilities in general management, research, finance, marketing and manufacturing across pharmaceutical, medical device and consumer franchises. He was appointed Vice President of Worldwide Quality. Most recently, Mr. Nugent had been Interim President, Chief Executive Officer and a Director of Biolase, Inc. Mr. Nugent has also served as Chairman, Director, President and Chief Executive Officer of a number of aesthetic medicine, medical device and consumer focused companies including Bioform, Inc. prior to its acquisition by Merz Aesthetics, Inc. He has also served on the Board of the Child Welfare League of America. Mr. Nugent holds a B.S. in mathematics from St. Joseph's College and earned an M.B.A. in finance and marketing from Loyola University in Chicago. He served as an Artillery Officer in the U.S. Army while assigned to military intelligence at the Pentagon.

Oliver Bennett , , , General Counsel and VP of Compliance & Legal

View bioHide bio

Oliver Bennett joined Sientra in 2015, first as outside counsel and then as general counsel to the company, prior to becoming General Counsel and Vice President for Compliance and Legal in 2018. Mr. Bennett brings with him almost two decades of experience in counseling medical device and life science companies in complex and high stakes legal issues. Prior to joining Sientra, Mr. Bennett practiced law at a number of premier firms where he was at the cutting edge of legal practice representing clients in ground-breaking cases that have helped shape US law. Most recently, Mr. Bennett was a partner at Kirkland & Ellis LLP. Before that, Mr. Bennett was Of Counsel at Kaye Scholer LLP (now Arnold White Kaye Scholer LLP), and an associate at Latham & Watkins, LLP and Clifford Chance US LLP. Mr. Bennett received a Master in Laws degree from Harvard Law School where he was also a Fulbright Scholar, and Bachelor of Laws and Bachelor of Arts degrees from Griffith University in Brisbane, Australia.

Deborah Bettencourt , , , Vice President, Customer Experience and Corporate Administration

View bioHide bio

Deborah Bettencourt joined Sientra in 2007. Ms. Bettencourt has nearly 20 years of experience in corporate operations and information technology within the medical device industry. She spent much of her professional career at Inamed Corporation (currently Allergan Medical). Ms. Bettencourt served as Director of Information Technology at Inamed Corporation where she was as an integral part of global information technology implementations, business acquisitions, system and process integrations, and international manufacturing expansions. Ms. Bettencourt is a member Society for Human Resource Management (SHRM) and holds a BA in Psychology from the University of California at Santa Barbara. Ms. Bettencourt also serves on the Board of Trustees for Marymount of Santa Barbara.

Dan Carlisle , , , Vice President of Innovation and Product Development

View bioHide bio

Dan Carlisle joined Sientra in 2007. Mr. Carlisle has nearly 30 years of innovative product design and development experience as well as technical expertise in the aesthetic/surgical market. Prior to joining Sientra, Mr. Carlisle was Senior Director, Technical Marketing at Inamed Corporation (currently Allergan Medical) where he was responsible for designing, refining and improving new products for the global aesthetic market. Additionally, he served as Director of the internationally recognized Inamed Academy™ (currently Allergan Academy ®), a global education and training platform for surgeons. He is named inventor or co-inventor on numerous patents in the aesthetic plastic surgery field. Before Inamed, Mr. Carlisle held various management positions at Silimed Corporation based out of Brazil and at McGhan Medical. Mr. Carlisle holds a BA in Art from California State University at Northridge.

Rosalyn d’Incelli , , , Vice President, Clinical Operations

View bioHide bio

Rosalyn d’Incelli joined Sientra in 2009. Ms. d’Incelli has more than 13 years of Clinical Research experience coupled with an accomplished record of clinical achievements. Prior to joining Sientra, she was the Director of Clinical Studies at Mentor Corporation, where she oversaw many of the company’s studies and managed their clinical resources. Ms. d’Incelli was a significant contributor to Mentor’s successful Silicone-Gel PMA approval, and at the time led the company’s large Post-Approval Silicone-Gel study. Additionally, she served as Clinical Director for Mentor’s phase 3 botulinum toxin studies and was previously involved in multiple urology studies. Prior to joining Mentor, Ms. d’Incelli was employed at Inamed Corporation (currently Allergan Medical) in Clinical Operations where she was a member of the clinical study team seeking approval for the company’s Silicone-Gel PMA. She has a demonstrated successful track record in the area of clinical operations with notable clinical studies completions in the areas of Breast and Facial Aesthetics and marketing approvals. Ms. d’Incelli holds a BA from the University of California Santa Barbara and is SoCRA board certified in Clinical Research.

Charles Huiner , , , Chief Operating Officer and Senior Vice President of Corporate Development and Strategy

View bioHide bio

Charlie Huiner joined Sientra in 2014 and brings with him a successful track record of nearly 25 years in business development, marketing, strategy and operations, where, in the past 15 years, he served in senior roles in the medical technology and device industries. Mr. Huiner's medical device and aesthetics experience includes 3 years at INAMED (now Allergan Medical) where, as Senior Director of Corporate Development and Strategy, his responsibilities spanned business development, strategy, corporate communications and investor relations. At INAMED, Mr. Huiner served a core role in a number of important partnership and in-licensing transactions including the acquisition of JUVÉDERM®, and he was also part of the senior transaction team that executed the $3.3 billion sale of INAMED to Allergan Medical. Immediately prior to joining Sientra, Mr. Huiner was at InTouch Health where he served as Vice President of Business Development and Marketing. At InTouch Health, he led a number of important strategic growth initiatives including conceiving of, building, and leading the Company's B-to-B surgical collaboration business. His extensive transactional and strategy transformation expertise is grounded by early career experience in operating and investing roles with Security Capital Group (now GE Capital) and ProLogis Trust. He began his career as an M&A financial analyst for NatWest Bancorp. Mr. Huiner earned a BA in History from Williams College, and an MBA in finance and marketing from Northwestern University's Kellogg School where he concentrated in healthcare management.

JoAnn Kuhne , , , Vice President, Regulatory Affairs & Quality Assurance

View bioHide bio

JoAnn Kuhne joined Sientra in 2006. Ms. Kuhne has more than twenty years of global regulatory and clinical experience. Prior to joining Sientra, Ms. Kuhne served as Senior Director, Regulatory Affairs at Inamed Corporation (now Allergan Medical) where she was instrumental in the company’s efforts to obtain PMA approval for the company’s silicone gel breast implants. Before Inamed, Ms. Kuhne was Director of Regulatory & Clinical Affairs at Medtronic PS Medical, leading the company’s global regulatory and clinical efforts for its neurosurgical implants. Preceding her career at Medtronic PS Medical and Inamed, Ms. Kuhne spent several years in the orthopedic implant industry as Manager of Regulatory Affairs for Smith and Nephew Orthopedics and Intermedics Orthopedics. Ms. Kuhne received her BSN from Northern Michigan University in Marquette, Michigan and an MSN from the University of North Carolina at Chapel Hill. She is a member of the Sigma Theta Tau International Honor Society and is board certified in Regulatory Affairs. Ms. Kuhne is an active volunteer at the Santa Ynez Valley Therapeutic Riding Center and is a sponsor for Threshold Ministries and Impact 2818.

Paul Little , , , Chief Financial Officer, Senior Vice President and Treasurer

View bioHide bio

Paul Little joined Sientra in 2018. He brings with him over 30 years of financial and operational management experience with public companies in the aesthetic space. Mr. Little most recently served as Chief Operating Officer at Syneron Candela, a leading global non-surgical aesthetic device company with a wide portfolio of medical aesthetic products. Prior to Syneron Candela, Mr. Little held several roles at Allergan including Vice President, Finance & Commercial Operations and Vice President, Assistant Corporate Controller. Mr. Little also currently serves on the Business Advisory Council at Plasticos Foundation, a nonprofit organization that provides resources for low and middle-income families worldwide. Mr. Little received a Bachelor’s degree in Business Economics with Honors from the University of California, Santa Barbara.

Valerie Miller , , , Vice President, Corporate Controller

View bioHide bio

Valerie Miller joined Sientra in 2017. She has over 20 years of financial management experience in both public and private healthcare and technology companies. Ms. Miller has held a variety of financial executive level positions.  Most recently, she held the senior financial positions at The Trade Desk, Inc, which went public in 2016 and at (which was acquired by LinkedIn in 2015).  Prior to that, Ms. Miller spent five years as VP Controller at Mentor Corporation (now Johnson & Johnson).  She was also VP Corporate Controller at QAD, Inc,, a public software company.  Earlier in her career, Ms Miller was in financial management at Allergan, Inc.  Ms Miller is a CPA and received a Bachelor of Arts in Business Economics with an emphasis in Accounting from the University of California, Santa Barbara.

Jason O’Hearn , , , Vice President of Sales and Professional Relations

View bioHide bio

Jason O’Hearn brings more than 18 years of aesthetic medical device experience to Sientra, 10 of those years were spent in senior/executive management positions. Prior to joining Sientra, Mr. O’Hearn was Vice President of Sales at Mentor Corporation WW LLC, a division of Johnson & Johnson. He was responsible for leading a team of approximately 110 sales professionals and his efforts resulted in Mentor becoming a world leader in breast implant sales. Mr. O’Hearn played a vital role in the introduction and acceptance of silicone gel implants into the U.S. market, and he has demonstrated a successful track record of moving market share in a highly competitive market. Mr. O’Hearn holds BA in Business Management and a minor in Finance from San Diego State University. Mr. O’Hearn is a volunteer for the Mesa Beautification Committee, which raises funds and awareness on how to keep our Santa Barbara beaches and parks clean.

Matthew Speitel , , , Vice President, Finance

View bioHide bio

Matthew Speitel joined Sientra in 2014. He brings with him more than 15 years of financial and operational management experience with both public and private companies. Previously, Mr. Speitel served as Vice President of Finance at Guitar Center, Inc., a multi-channel retail company focused on providing musical instruments and services. Mr. Speitel was at Guitar Center for approximately five years and was responsible for the finance and accounting functions, development of the consolidated budget and forecast, and driving operational efficiencies to support top-line and operating margin growth. Prior to Guitar Center, Mr. Speitel held roles of increasing responsibility at KPMG LLP, serving most recently as Audit Manager. His public accounting experience focused primarily on managing mid to large cap engagements (including SEC registrants) in the consumer products, technology and manufacturing industries. Mr. Speitel is a Certified Public Accountant and received a Bachelor of Science in Accounting from the California Lutheran University.

Patrick F. Williams , , , General Manager, miraDry

View bioHide bio

Patrick Williams joined Sientra in 2016, and became the General Manager of miraDry in 2018. He brings more than 9 years of experience in the medical device industry, most recently serving as Senior Vice President and Chief Financial Officer at ZELTIQ Aesthetics, a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. Mr. Williams was at ZELTIQ for approximately four years and was responsible for executive management of the finance and investor relations functions, development of the worldwide budget and forecast, and implementation of necessary infrastructure changes to support top-line growth and operating margin expansion. Prior to ZELTIQ, Mr. Williams served as Vice President of Strategy and Investor Relations and Vice President of Finance and Investor Relations at NuVasive, a medical device company focused on developing minimally surgical products for the spine. Mr. Williams also currently serves on the Board of Directors of Miramar Labs, a medical device company that markets miraDRY®, a system designed for the treatment of hyperhidrosis. Mr. Williams received an MBA in Finance and Management from San Diego State University and a Bachelor of Arts in Economics from University of California, San Diego.


Stock Quote: NASD

$18.25 -0.73
Volume 251,081
Previous Close 18.98
Intraday High 19.38
Intraday Low 18.10
Pricing delayed 20 minutes
Price Change % Change -3.85% 52 Week High 26.79 52 Week Low 8.79 Today's Open 19.00 Nov 16, 2018 04:00 PM

Investor Contact

Sientra Investor Relations